
Study #lymphoma, #epigenetics, #protac, #immune @PMcancercentre🇨🇦 | Founder @UHNPostdocs | Delegate @OICRRisingStars | Alum @PeterMacCC🇦🇺
Toronto, Ontario
Joined May 2021
- Tweets442
- Following287
- Followers227
- Likes2.8K
Michael He, Ph.D., BPharm (Hons) retweeted
We are looking for a talented postdoctoral bioinformatician @TheDawsonLab to work with us on single cell multiomics incorporating lineage tracing and spatial technologies- we specifically want someone curious, fearless with a licence to innovate!! nature.com/naturecareers/job…
Michael He, Ph.D., BPharm (Hons) retweeted
UHN is proud to be ranked #1 on the list of Canada’s Top 40 Research Hospitals from @R_Infosource for the 14th year in a row!
Thanks to our incredible research community for their continued dedication to #HealthDiscovery, #care & #education!
🔗uhnresearch.ca/news/uhn-isca…
Michael He, Ph.D., BPharm (Hons) retweeted
Can we turn the activity of oncogenic kinases against cancer itself?
In my postdoc work @Stanford, new in @sciencemagazine, we show exactly that.
science.org/doi/10.1126/scie…
#ScienceResearch #InducedProximity @Stanford_ChEMH @StanfordCancer @snsf_ch @StanfordMed
Michael He, Ph.D., BPharm (Hons) retweeted
Transcriptional/epigenetic chemical inducers of proximity (TCIPs) are an innovative new class of therapeutics that are set to impact lymphoma and other malignancies. Here @RomanSarott, @saigourisankar describe a CDK9 "catch and release" MOA for a new TCIP.
science.org/doi/10.1126/scie…
Michael He, Ph.D., BPharm (Hons) retweeted
As #BloodCancerAwarenessMonth wraps up, we want to congratulate @PMResearch_UHN’s Dr. Robert Kridel @rkridel for publishing three new studies on #lymphoma.
Learn about his team’s dedication to advancing cancer research:
📽️youtu.be/XP0Tnwt2iHY
Michael He, Ph.D., BPharm (Hons) retweeted
In vivo CRISPR screen of Epigenetic regulators identity therapeutic targets that rely on tumor microenvironment - our recent work is out at Nature Genetics nature.com/articles/s41588-0…
Great teamwork @SoundTsao @DanielSchramek @decarvalho_lab @brooks_lab @kuraoncology and many others
Michael He, Ph.D., BPharm (Hons) retweeted
👏👏 Super kudos to @pmcancercentre @rkridel for this outstanding translational work in follicular #lymphoma.
From 713 tumor tissue samples (eg, E4402, E2408 & GALLIUM), 5 genetic subtypes discovered and a/w clinicopath findings & pt outcomes.
👉👉 SEE: rdcu.be/dQmEk
Michael He, Ph.D., BPharm (Hons) retweeted
Our perspective on the synergistic activity of HDAC3i and GNAS silencing in CREBBP wild type B cell lymphoma #RobertKridel @themichaelhe #PrincessMargaretCancerCenter @MayoClinic nature.com/articles/s41375-0…
Michael He, Ph.D., BPharm (Hons) retweeted
Our HDAC8 degrader work is now online in JMC! Many thanks to the teams and PIs. Special thanks to colleagues @themichaelhe, Tom Lin& @RashmiKarki12. Stay tuned for more exciting discoveries!
Discovery of a Highly Potent and Selective HDAC8 Degrader: Advancing the Functional Understanding and Therapeutic Potential of HDAC8 | Journal of Medicinal Chemistry pubs.acs.org/doi/10.1021/acs…
Michael He, Ph.D., BPharm (Hons) retweeted
New research led by Professor @MAF_Dawson has found the answer to a decades-long question on cell functioning that could lead to improved #cancer treatments in the future.
Find out more 👇petermac.org/about-us/news-a…
Michael He, Ph.D., BPharm (Hons) retweeted
🚨Attention Postdocs! We're excited to announce the launch of our 2024 UHNPA leadership groups recruitment! 🎉 Open to all UHN postdocs!
Want to boost your CV, expand professional network, get priority access to events, or be seen on UHNPA social media? join us now! 🤩
Michael He, Ph.D., BPharm (Hons) retweeted
I am so very proud of @charles_bell92 and this manuscript from @TheDawsonLab @PeterMacRes - A labour of love driven by curiosity, resilience and incredible teamwork over many years. We hope it contributes substantially to our field nature.com/articles/s41588-0…
Michael He, Ph.D., BPharm (Hons) retweeted
Researchers in Canada got most of what they were hoping for in the country’s 2024 federal budget, with a big boost in postgraduate pay and more funding for research and scientific infrastructure go.nature.com/4azQ8Ft
Michael He, Ph.D., BPharm (Hons) retweeted
**Is single-cell data integration a solved problem? **
Lots of great methods, but still not quite yet! Specifically, Check Dataset Imbalance!
🎉 Excited to announce that our study on dataset imbalances in single-cell analysis just hit Nature Biotechnology (@NatureBiotech)! 🎉 Dive into our paper titled "Characterizing the impacts of dataset imbalance on single-cell data integration" here: nature.com/articles/s41587-0…
🔬 We've thoroughly assessed how dataset imbalances can twist the results of single-cell integration and batch-correction, affecting everything from cell-type classification to differential expression. Our work doesn't just highlight the issue; it offers solid solutions!
🧩 Starting with balanced PBMC data, we uncovered how changing cell-type balance disrupts integration results. But, when we cluster similar cell-types hierarchically, the magic happens – stability is dramatically improved!
📊 We didn't stop there. Our research extends to how these imbalances influence crucial downstream analyses. The impact? Statistically significant changes that could sway biological conclusions.
🛠️ To empower researchers, we've developed a suite of guidelines and introduced innovative balanced clustering metrics. Our tools are designed to navigate the tricky waters of dataset imbalance, ensuring accurate, meaningful results. Check out our full tutorial: github.com/hsmaan/Iniquitate…
🧬 And, for a cherry on top, we've redefined benchmarking standards with new metrics that ensure fair and nuanced interpretation of integration results. Future benchmarking, we've got you covered! Explore our balanced clustering package: github.com/hsmaan/balanced-c…
🔧 Our comprehensive toolkit, including code, data, and detailed documentation, is now fully open-source! We're setting new standards for method development and benchmarking in single-cell integration, with an eye on the broader horizon of representation learning. Get all the goodies here: github.com/hsmaan/Iniquitate
Huge congratulations to all the authors, especially the first author, Hassaan Maan, a PhD student I co-supervise with @kieranrcampbell, who almost single-handedly led this project!
@UHN @MBPatUofT @VectorInst @UofTCompSci @UofT_LMP @pmcc_ai @UHNAIHUB
Michael He, Ph.D., BPharm (Hons) retweeted
Pre-trained using over 33 million single cell RNA-seq profiles, scGPT is a foundation model facilitating a broad spectrum of downstream single-cell analysis tasks by transfer learning. @BoWang87 @HAOTIANCUI1 @ChloeXWang1 @UofT @VectorInst @UHN
nature.com/articles/s41592-0…
Michael He, Ph.D., BPharm (Hons) retweeted
One of the primary‘products’ of investment in research is talent. We are 500,000 short and falling further behind every year. Canada needs to invest in talent development through research
This Post is from an account that no longer exists. Learn more
Michael He, Ph.D., BPharm (Hons) retweeted
So thrilled to see this wonderful body of work from Vi Wickramasinghe's lab at @PeterMacRes along with Greg Goodall @CCB_Research - a fundamental discovery with potentially major implications for RNA therapy nature.com/articles/s41586-0…
Michael He, Ph.D., BPharm (Hons) retweeted
My lab is looking to recruit a postdoc. Full details available at jobrxiv.org/job/lupien-lab-a…





























